99mTc-depreotide生长抑素受体显像的临床应用研究

郭睿 晋建华

引用本文:
Citation:

99mTc-depreotide生长抑素受体显像的临床应用研究

    通讯作者: 晋建华, jjhl225@126.com
  • 中图分类号: R817.4

The clinical application and study of 99mTc-depreotide somatostatin receptor imaging

    Corresponding author: JIN Jian-hua, jjhl225@126.com
  • CLC number: R817.4

  • 摘要: 生长抑素受体显像近年来研究较多,depreotide已成为其研究热点之一.Depreotide在诊断与鉴别诊断临床常见的孤立性肺结节方面有其独特优势;此外,99mTc-depreotide生长抑素受体显像在乳腺癌、甲状腺癌、淋巴瘤等肿瘤及甲状腺相关性眼病等非肿瘤性疾病也有一定应用前景.
  • [1] Thomas LP,Balingit AG,Morison DS,et al.False-positive technetium 99m depreotide scintigraphy resulting from round atelectasis.J Thorac Imaging; 2003,18(2):97-99.
    [2] Blum JE,Handmaker H,Rinne NA,et al.Technetium labeled small peptide radiopharmaceuticals in the identification of lung cancer.Curr Pharm Des,2002,8(20):1827-1836.
    [3] Ferran N,Ricart Y,Lopez M,et al.Characterization of radiologically indeterminate lung lesions:99mTc-depreotide SPECT versus 18F-FDG PET,Nucl Med Commun,2006,27(6):507-514.
    [4] Gould MK,Maclean CC,Kuschner WG,et al.Accuracy of positron emission tomography for diagnosis of pulmonary nodules and mass lesions:a meta-analysis.JAMA,2001,285(7):914-924.
    [5] Danielsson R,Baath M,Svensson L,et al.Imaging of regional lymph node metastases with 99mTc-depreotide in patients with lung cancer.Eur J Nucl Med Mol Imaging,2005,32(8):925-931.
    [6] Mena E,Camacho V,Estorch M,et al.99mTc-depreotide scinti-graphy of bone lesions in patients with lung cancer.Eur J Nucl Med Mol Imaging,2004,31(10):1399-1404.
    [7] Grewal RK,Dadparvar S,Yu JQ,et al.Efficacy of Tc-99m depreotide scintigraphy in the evaluation of solitary pulmonaiy nodules.Cancer J,2002,8(5):400-404.
    [8] Naalsund A,Maublant J.The solitary pulmonary nodule-is it malignant or benign? Diagnostic performance of 99mTc-depreotide SPECT.Respiration,2006,73(5):634-641.
    [9] Kahn D,Menda Y,Kemstine K,et al.The utility of 99mTc-depreotide compared with F-18 fluorodeoxyglucose positron emission tomography and surgical staging in patients with suspected nonsmall cell lung cancer.Chest,2004,125 (2):494-501.
    [10] Van Den Bossche B,Van Belle S,De Winter F,et al.Early prediction of endocrine therapy effect in advanced breast cancer patients using 99mTc-depreotide scintigraphy. J Nucl Med,2006,47(1):6-13.
    [11] Burggasser G,Hurtl I,Hauff W,et al.Orbital scintigraphy with the somatostatin receptor tracer 99mTc-PBIQ in patients with Graves' disease.J Nucl Med,2003,44(10):1547-1555.
    [12] Cholewinski W,Kowalczyk JR,Stefaniak B,et al.Diagnosis and staging of children's lymphoma using the technetium-labelled somatostatin analogue,99mTc-depreotide.Eur J Nucl Med Mol Imaging,2004,31(6):820-824.
    [13] Vaisamaki P,Gotzamani-Psarrakou A,Tsiouris S,et al.Tc-99m depreotide imaging of I-131-negative recurrent metastatic papillary thyroid carcinoma.Int J Cancer,2006,119(4):968-970.
    [14] Blankenberg FG,Mari C,Strauss HW.Development of radiocontrast agents for vascular imaging:progress to date.Am J Cardiovasc Drugs,2002,2(6):357-365.
  • [1] 侯仁花吕中伟 . 生长抑素受体显像剂99mTc-depreotide的研究进展. 国际放射医学核医学杂志, 2008, 32(1): 15-18.
    [2] 王佳琼王自正姚薇萱王峰 . 乳腺肿瘤生长抑素受体表达与生长抑素受体显像. 国际放射医学核医学杂志, 2006, 30(1): 17-21.
    [3] 王秀娟李险峰 . 生长抑素受体肿瘤显像的临床应用及研究进展. 国际放射医学核医学杂志, 2006, 30(4): 217-219.
    [4] 段炼李险峰 . 甲状腺相关眼病与生长抑素受体显像. 国际放射医学核医学杂志, 2005, 29(3): 108-111.
    [5] 谭兴普黄艳99Tcm-MIBI亲肿瘤延迟断层显像对肺占位病灶的诊断价值. 国际放射医学核医学杂志, 2010, 34(5): 297-299. doi: 10.3760/cma.j.issn.1673-4114.2010.05.012
    [6] 邓智勇杨丽春 . 肺肿瘤核素显像的临床应用进展. 国际放射医学核医学杂志, 2008, 32(5): 295-299.
    [7] 李亚军白人驹高硕李彦生刘磊贾薇蔡莉邢喜玲 . 兔VX2肺肿瘤PET-CT与血管生成的相关性研究. 国际放射医学核医学杂志, 2010, 34(3): 139-142. doi: 10.3760/cma.j.issn.1673-4114.2010.03.003
    [8] 夏俊勇王火强 . 以血管内皮生长因子及其受体为靶向的肺癌放射性核素显像. 国际放射医学核医学杂志, 2008, 32(2): 82-85.
    [9] 杨爱民彭志远胡国瑛孟宪文99mTc-MIBI:用于肿瘤阳性显像. 国际放射医学核医学杂志, 1996, 20(6): 257-259.
    [10] 陈贵兵欧阳忠韩成坤黄劲雄何小江王凡贾兵吴华99Tcm-3PRGD2整合素受体显像在乳腺癌定性诊断中的价值及与钼靶检查的对比研究. 国际放射医学核医学杂志, 2017, 41(1): 1-7. doi: 10.3760/cma.j.issn.1673-4114.2017.01.001
  • 加载中
计量
  • 文章访问数:  1416
  • HTML全文浏览量:  166
  • PDF下载量:  5
出版历程
  • 收稿日期:  2006-11-20

99mTc-depreotide生长抑素受体显像的临床应用研究

    通讯作者: 晋建华, jjhl225@126.com
  • 030001 太原, 山西医科大学第一医院核医学科

摘要: 生长抑素受体显像近年来研究较多,depreotide已成为其研究热点之一.Depreotide在诊断与鉴别诊断临床常见的孤立性肺结节方面有其独特优势;此外,99mTc-depreotide生长抑素受体显像在乳腺癌、甲状腺癌、淋巴瘤等肿瘤及甲状腺相关性眼病等非肿瘤性疾病也有一定应用前景.

English Abstract

参考文献 (14)

目录

    /

    返回文章
    返回